Anemia is a decrease in the total amount of red blood cells (RBCs) or hemoglobin in the blood,[3][4] or a lowered ability of the blood to carry oxygen.[5] When anemia comes on slowly, the symptoms are often vague and may include feeling tired, weakness, shortness of breath or a poor ability to exercise.
This report contains market size and forecasts of Anemia Treatment in Global, including the following market information:
Global Anemia Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Anemia Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Route Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anemia Treatment include Pfizer, Johnson & Johnson, Roche, Novartis, Amgen, Bayer, GlaxoSmithKline, Teva Pharmaceutical and Novo Nordisk, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anemia Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anemia Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Anemia Treatment Market Segment Percentages, by Type, 2021 (%)
Oral Route
Injectable Route
Global Anemia Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Anemia Treatment Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Anemia Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Anemia Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anemia Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Anemia Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Johnson & Johnson
Roche
Novartis
Amgen
Bayer
GlaxoSmithKline
Teva Pharmaceutical
Novo Nordisk
CSL Limited
AMAG Pharmaceuticals
Rockwell Medical
Akebia Therapeutics
Vifor Pharma